Pfizer Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	149,211	141,581	150,346	162,548	287,764	331,861
Market Cap Growth	19.19%	-5.83%	-7.51%	-43.51%	-13.29%	61.95%
Enterprise Value	200,861	193,079	194,514	222,020	301,117	339,490
Last Close Price	26.18	24.90	26.53	28.79	51.24	59.05
PE Ratio	19.98	18.31	18.82	77.81	9.37	15.34
Forward PE	9.19	8.54	9.91	19.25	10.82	10.64
PEG Ratio	-	-	1.27	-	-	1.00
PS Ratio	2.36	2.26	2.36	2.73	2.84	4.08
PB Ratio	1.66	1.64	1.70	1.83	3.01	4.30
P/TBV Ratio	1.66	1.65	1.71	1.85	3.07	4.37
P/FCF Ratio	15.73	15.60	15.29	33.91	11.05	11.11
P/OCF Ratio	12.45	12.10	11.80	18.68	9.83	10.19
EV/Sales Ratio	3.17	3.09	3.06	3.73	2.98	4.18
EV/EBITDA Ratio	7.89	13.68	12.94	30.22	7.57	11.51
EV/EBIT Ratio	10.62	25.68	24.24	210.05	8.67	13.96
EV/FCF Ratio	21.18	21.28	19.78	46.32	11.57	11.37
Debt / Equity Ratio	0.71	0.75	0.73	0.81	0.37	0.50
Debt / EBITDA Ratio	4.45	4.59	4.28	9.79	0.90	1.30
Debt / FCF Ratio	6.80	7.14	6.54	15.00	1.38	1.29
Net Debt / Equity Ratio	0.57	0.59	0.50	0.67	0.14	0.10
Net Debt / EBITDA Ratio	3.55	3.63	2.92	8.06	0.33	0.25
Net Debt / FCF Ratio	5.42	5.64	4.46	12.35	0.50	0.25
Asset Turnover	0.30	0.30	0.29	0.28	0.53	0.48
Inventory Turnover	1.57	1.49	1.70	2.60	3.81	3.61
Quick Ratio	0.75	0.69	0.74	0.51	0.80	1.00
Current Ratio	1.25	1.16	1.17	0.91	1.22	1.40
Return on Equity (ROE)	8.49%	8.89%	9.06%	2.35%	36.22%	31.87%
Return on Assets (ROA)	3.62%	3.69%	3.66%	1.02%	16.58%	13.38%
Return on Invested Capital (ROIC)	4.03%	4.22%	4.15%	1.18%	20.54%	16.26%
Return on Capital Employed (ROCE)	4.59%	4.40%	4.60%	0.63%	23.63%	18.20%
Earnings Yield	5.02%	5.46%	5.31%	1.29%	10.68%	6.52%
FCF Yield	6.36%	6.41%	6.54%	2.95%	9.05%	9.00%
Dividend Yield	6.58%	6.90%	6.33%	5.69%	3.13%	2.64%
Payout Ratio	131.03%	125.74%	118.44%	436.39%	28.63%	39.72%
Buyback Yield / Dilution	-0.26%	-0.23%	0.16%	0.42%	-0.44%	-1.35%
Total Shareholder Return	6.32%	6.68%	6.49%	6.11%	2.69%	1.29%

SEC Filings: 10-K · 10-Q